The pathophysiology of heart failure with preserved ejection fraction
Crossref DOI link: https://doi.org/10.1038/nrcardio.2014.83
Published Online: 2014-06-24
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Borlaug, Barry A.
Text and Data Mining valid from 2014-06-24
Article History
First Online: 24 June 2014
Competing interests
: The author has acted as a consultant for: Amgen, Cardiokinetix, DC Devices (unpaid), GlaxoSmithKline, and Merck. He has received research support from AtCor Medical.